FDA has removed certain bulk drug substances that were placed on the category two list and has announced it will consult the Pharmacy Compounding Advisory Committee (PCAC) for potential future inclusion of FDA Proposes Exclusion of Semaglutide, Tirzepatide, Liraglutide from 503B Bulks List FDA posted on the topic LinkedIn FDA July 2026 Peptide Meeting: What Patients Need to Know About Access, Approval, and Safety Meto blog The FDA just announced that they're taking steps to lift restrictions on 12 peptides including BPC 157 and TB 500 making them accessible through compounding pharmacies again. This is a HUGE step
Shopping security
Each payment you make on thelockerguy is secured with strict SSL encryption and PCI DSS data protection protocols
product description
Why choose thelockerguy wholesale?
Show More
fda category 2 bulk drug substances list bpc-157 ๐จ BREAKING: FDA UPDATES CATEGORY 2 BULKS LIST -- OFFICIALLY REMOVES PEPTIDES LIKE BPC-157 The first opportunity for reclassification comes on July 23-24 during the FDA's PCAC meeting Until then, peptides are